Avicanna Inc: Impressive Pedigree, Global Ambitions: Capital Ideas TV

Capital Ideas publisher Mark Bunting speaks with Avicanna Inc. (TSX:AVCN) CEO Aras Azadian


SmallCapPower partner Capital Ideas presents a special segment of Capital Ideas TV. In this episode, Mark Bunting, President and Publisher of Capital Ideas Media, sits down with Aras Azadian, CEO, Chairman and Co-Founder of newly-public Avicanna Inc. (TSX:AVCN). This is a biopharmaceutical company focused on science and evidence-based delivery that has partnerships with several large hospitals such as Princess Margaret, and pharmaceutical giant Johnson & Johnson. Azadian explains Avicanna’s low-cost cultivation in Colombia and its four verticals structure in agriculture, medical, consumer and pharma. He also discusses how the Company does things the right way, and why it’s setting gold standards as it scales up into a global leader.

Ubika Research/SmallCapPower has received compensation from Avicanna to provide analyst research coverage. For full disclosure please visit here >>

To read our full disclosure, please click on the button below: